RL

Robert LeBoyer

#413 out of 1699 analysts
Noble Capital Markets
Automatically Tracked
Tracking: 0 Updated: Yesterday at 02:27 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
18.05%
Gain
Monthly
0.3%
Yearly
3.71%
Drawdown
52.68%
$1.17M
Equity
Holdings
$1,601.68
Cash
$1.17M
Investment
$967
$164,625.15
Profit +$5.82
Realized
$163,990.47
Unrealized
$634.69
Dividends
$0
$1.17M
Cash
Deposits
$1M
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0%
Profit
$5.82
Win %
100%
This Week
Compared To Last Week
Gain
-0.001%
Profit
-$7.48
Win %
100%
This Month
Compared to last month
Gain
0.002%
Profit
$21.62
Win %
100%
This Year
Compared to last year
Gain
0.01%
Profit
$100.61
Win %
100%
Geovax Labs Inc. logo
GOVX Geovax Labs Inc.
+13.56%
$0
Tonix Pharmaceuticals Holding Corp logo
TNXP Tonix Pharmaceuticals Holding Corp
-1.72%
+$5.82
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
35
Longs Won
10/26 38%
Profit Factor
1.28
Profitability
Shorts Won
3/9 33%
Standard Deviation
$77,041.75
Average Win
$57,993.16
Best Trade
(Mar 20) $283,266.97
Sharpe Ratio
-50
Average Loss
-$26,785.72
Worst Trade
(Nov 27) -$265,530.09
Z-Score
-2.52 (100%)
Commissions
$0
Avg. Trade Length
5m 1d
Expectancy
$4,703.58
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% 1.62% 5.6% 11.57% 19.37% 28.89% 40.05% 52.79% 67.05% 82.8%
Consecutive Losing Trades 44 39 35 31 26 22 17 13 9 4
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV